Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $60.8B | $62.3B | $1.26B | $1.29B | $1.35B | $2.07B | $2.11B | $2.23B | $2.25B | $2.44B |
| Revenue growth | — | 2.5% | -98.0% | 2.6% | 5.0% | 53.2% | 1.7% | 5.6% | 0.7% | 8.5% |
| Operating income | — | — | — | — | — | — | $5.98B | $5.72B | $6.00B | $6.14B |
| Operating margin | — | — | — | — | — | — | 283.3% | 256.8% | 267.1% | 251.9% |
| Net income | $850M | $4.01B | $5.12B | $5.90B | $5.41B | $6.86B | $5.28B | $1.58B | $4.43B | $3.38B |
| Net margin | 1.4% | 6.4% | 407.9% | 457.6% | 399.3% | 330.5% | 250.4% | 70.8% | 197.1% | 138.7% |
| EPS (diluted) | $0.67 | $3.62 | $4.91 | $6.06 | $5.68 | $7.65 | $6.30 | $1.81 | $5.94 | $4.71 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $14.8B | $12.3B | $11.7B | $13.8B | $11.6B | $12.3B | $13.0B | $13.7B | $14.6B | $17.1B |
| Share buybacks | $372M | $2.93B | $3.99B | $2.29B | $1.15B | $4.30B | $3.33B | $3.10B | $3.21B | $2.88B |
| Dividends paid | $1.74B | $1.72B | $1.68B | $1.64B | $1.66B | $1.65B | $1.60B | $1.57B | $1.53B | $1.51B |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $12.7B | $12.7B | $15.8B | $16.6B | $19.8B | $20.0B | $20.2B | $20.6B | $20.1B | $22.0B |
| Total assets | $899B | $720B | $688B | $740B | $795B | $760B | $663B | $688B | $677B | $745B |
| Total liabilities | $831B | $661B | $635B | $674B | $720B | $692B | $633B | $657B | $650B | $716B |
| Shareholders' equity | $67.5B | $58.7B | $52.7B | $66.1B | $74.6B | $67.5B | $29.9B | $30.0B | $27.4B | $28.4B |
| Retained earnings | $34.7B | $26.5B | $28.9B | $33.1B | $36.5B | $31.8B | $40.3B | $40.1B | $42.6B | $44.3B |
| Shares (wtd avg diluted) | 1.11B | 1.08B | 1.01B | 944M | 913M | 869M | 809M | 762M | 711M | 673M |
Every figure is extracted from METLIFE INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.